Loading...
Treatment Stratification of Patients with Metastatic Castration-Resistant Prostate Cancer by Machine Learning
Prostate cancer is the most common cancer in men in the Western world. One-third of the patients with prostate cancer will develop resistance to hormonal therapy and progress into metastatic castration-resistant prostate cancer (mCRPC). Currently, docetaxel is a preferred treatment for mCRPC. Howeve...
Na minha lista:
| Udgivet i: | iScience |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6976944/ https://ncbi.nlm.nih.gov/pubmed/31978751 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.isci.2019.100804 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|